Anti-inflammatory effects of topically applied dimethyl sulfoxide gel on endotoxin-induced synovitis in horses. 1998

G Smith, and A L Bertone, and C Kaeding, and E J Simmons, and S Apostoles
Department of Orthopedic Surgery, College of Medicine, The Ohio State University, Columbus 43210, USA.

OBJECTIVE To evaluate the effect of topically applied dimethylsulfoxide (DMSO) on lipopolysaccharide (LPS)-induced synovitis in the mid-carpal joint. METHODS 6 sound, healthy, adult horses (12 carpi). METHODS In a double-blinded, crossover, paired study with a 1-week washout period, mid-carpal joints were allocated to group 1 (DMSO, n = 6) or group 2 (control, n = 6). Each joint was injected with 1.3 ml (0.0125 ng/dl) of LPS to induce synovitis. For group-1 joints, DMSO gel (15 g; 90%) was applied after injection of LPS and at 12-hour intervals for 60 hours. Joints of group 2 received LPS, but not DMSO gel. All horses were evaluated by serial lameness examinations and synovial fluid analyses (total and differential WBC count and total protein concentration) at 12-hour intervals for 60 hours after LPS injection. Plasma and synovial fluid were obtained at baseline and 36 hours to document presence of DMSO. RESULTS Mean WBC concentration was significantly (P < 0.05) lower in group-1, compared with group-2 joints, at 24 hours and had a trend to be lower at 36 hours. Mean total neutrophil count was significantly lower in group-1, compared with group-2 joints at 24 hours. In group-1 joints, DMSO was detected by use of gas chromatography in the synovial fluid of 5 of 6 joints and in plasma from 1 of 6 horses. CONCLUSIONS Topically applied DMSO penetrated into synovial fluid in sufficient quantities to be detected and to decrease joint inflammation.

UI MeSH Term Description Entries
D007794 Lameness, Animal A departure from the normal gait in animals. Gait Disorders, Animal,Animal Gait Disorder,Animal Gait Disorders,Animal Lameness,Animal Lamenesses,Disorder, Animal Gait,Disorders, Animal Gait,Gait Disorder, Animal,Lamenesses, Animal
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D004121 Dimethyl Sulfoxide A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation. DMSO,Dimethyl Sulphoxide,Dimethylsulfoxide,Dimethylsulphinyl,Dimethylsulphoxide,Dimexide,Rheumabene,Rimso,Rimso 100,Rimso-50,Sclerosol,Sulfinylbis(methane),Rimso 50,Rimso50,Sulfoxide, Dimethyl,Sulphoxide, Dimethyl
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005782 Gels Colloids with a solid continuous phase and liquid as the dispersed phase; gels may be unstable when, due to temperature or other cause, the solid phase liquefies; the resulting colloid is called a sol.
D006734 Horse Diseases Diseases of domestic and wild horses of the species Equus caballus. Equine Diseases,Disease, Equine,Disease, Horse,Diseases, Equine,Diseases, Horse,Equine Disease,Horse Disease
D006736 Horses Large, hoofed mammals of the family EQUIDAE. Horses are active day and night with most of the day spent seeking and consuming food. Feeding peaks occur in the early morning and late afternoon, and there are several daily periods of rest. Equus caballus,Equus przewalskii,Horse, Domestic,Domestic Horse,Domestic Horses,Horse,Horses, Domestic
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

G Smith, and A L Bertone, and C Kaeding, and E J Simmons, and S Apostoles
January 1975, Annals of the New York Academy of Sciences,
G Smith, and A L Bertone, and C Kaeding, and E J Simmons, and S Apostoles
December 1966, Experientia,
G Smith, and A L Bertone, and C Kaeding, and E J Simmons, and S Apostoles
April 1985, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
G Smith, and A L Bertone, and C Kaeding, and E J Simmons, and S Apostoles
January 1986, The American journal of sports medicine,
G Smith, and A L Bertone, and C Kaeding, and E J Simmons, and S Apostoles
May 1968, Experientia,
G Smith, and A L Bertone, and C Kaeding, and E J Simmons, and S Apostoles
January 2010, American journal of veterinary research,
G Smith, and A L Bertone, and C Kaeding, and E J Simmons, and S Apostoles
February 1979, Japanese journal of pharmacology,
G Smith, and A L Bertone, and C Kaeding, and E J Simmons, and S Apostoles
July 1979, The British journal of dermatology,
G Smith, and A L Bertone, and C Kaeding, and E J Simmons, and S Apostoles
September 2003, Biological & pharmaceutical bulletin,
G Smith, and A L Bertone, and C Kaeding, and E J Simmons, and S Apostoles
January 1959, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Copied contents to your clipboard!